Tallman, Martin

Publications

Sort by

Co-Author Network

selected publications

Late and very late relapses in acute myeloid leukemia (AML). Leukemia & lymphoma. 2020 Comment GET IT
Oral arsenic trioxide ORH-2014 pharmacokinetic and safety profile in patients with advanced hematologic disorders. Haematologica. 2019 Academic Article GET IT
Times cited: 2
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Review GET IT
Times cited: 14
The Role of Abnormal Hemostasis and Fibrinolysis in Morbidity and Mortality of Acute Promyelocytic Leukemia. Seminars in thrombosis and hemostasis. 2019 Academic Article GET IT
Times cited: 5
Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer. Leukemia research. 2019 Academic Article GET IT
Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML. Cancer discovery. 2019 Academic Article GET IT
Times cited: 13
Exciting Times in Acute Myeloid Leukemia. Seminars in hematology. 2019 Editorial Article GET IT
Time to repeal and replace response criteria for acute myeloid leukemia?. Blood reviews. 2019 Review GET IT
Times cited: 19
Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib. Blood. 2018 Academic Article GET IT
Times cited: 92
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900. Haematologica. 2018 Letter GET IT
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations. Nature. 2018 Academic Article GET IT
Times cited: 77
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML. The New England journal of medicine. 2018 Academic Article GET IT
Times cited: 372
Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study. The Journal of infection. 2018 Academic Article GET IT
Times cited: 13
New therapeutic strategies for high-risk acute myeloid leukemia. Current opinion in hematology. 2018 Review GET IT
Times cited: 3
Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up. Blood. 2018 Academic Article GET IT
Times cited: 26
Widespread use of measurable residual disease in acute myeloid leukemia practice. Leukemia research. 2018 Academic Article GET IT
Times cited: 4
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. Cancer discovery. 2018 Academic Article GET IT
Times cited: 22
Disease characteristics and clinical outcomes in patients aged less than 40 with chronic lymphocytic leukemia. Leukemia research. 2018 Academic Article GET IT
Times cited: 1
Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses. Leukemia research. 2018 Academic Article GET IT
Times cited: 6
Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia. American journal of hematology. 2017 Academic Article GET IT
Times cited: 43
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. Cell stem cell. 2017 Academic Article GET IT
Times cited: 212
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 6
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation. The New England journal of medicine. 2017 Academic Article GET IT
Times cited: 656
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia. Blood. 2017 Academic Article GET IT
Times cited: 504
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials. Leukemia research. 2017 Academic Article GET IT
Times cited: 12
Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells. Nature genetics. 2017 Academic Article GET IT
Times cited: 33
The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia. Oncotarget. 2017 Academic Article GET IT
Times cited: 17
Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide. Leukemia. 2017 Academic Article GET IT
Times cited: 19
Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 7
Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 66
Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE). International journal of hematology. 2017 Academic Article GET IT
Times cited: 9
Synergistic antileukemic therapies in NOTCH1-induced T-ALL. Proceedings of the National Academy of Sciences of the United States of America. 2017 Academic Article GET IT
Times cited: 22
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 24
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia. Journal for immunotherapy of cancer. 2016 Academic Article GET IT
Times cited: 10
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood. 2016 Review GET IT
Times cited: 80
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2016 Review GET IT
Times cited: 1591
High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 150
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling. Nature medicine. 2016 Academic Article GET IT
Times cited: 96
Down for the count in acute myeloid leukemia. Blood. 2016 Comment GET IT
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nature genetics. 2016 Academic Article GET IT
Times cited: 99
A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia. Cancer medicine. 2016 Academic Article GET IT
Times cited: 21
Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 38
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia. Acta haematologica. 2016 Academic Article GET IT
Times cited: 5
The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance. Leukemia research. 2016 Academic Article GET IT
Times cited: 7
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII. American journal of hematology. 2016 Academic Article GET IT
Times cited: 4
Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia. Leukemia research. 2016 Academic Article GET IT
Times cited: 8
Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia. Haematologica. 2016 Letter GET IT
Times cited: 15
Treatment outcomes and secondary cancer incidence in young patients with hairy cell leukaemia. British journal of haematology. 2016 Academic Article GET IT
Times cited: 14
Maintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials. Blood. 2016 Academic Article GET IT
Times cited: 19
Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias. Leukemia. 2016 Academic Article GET IT
Times cited: 31
How I treat acute myeloid leukemia presenting with preexisting comorbidities. Blood. 2016 Review GET IT
Times cited: 18
Autologous transplant remains the preferred therapy for relapsed APL in CR2. Bone marrow transplantation. 2016 Academic Article GET IT
Times cited: 18
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 38
DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia. Cancer discovery. 2016 Academic Article GET IT
Times cited: 39
Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary. Bone marrow transplantation. 2016 Letter GET IT
Times cited: 3
Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission. American journal of hematology. 2016 Academic Article GET IT
Times cited: 38
What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?. Current opinion in hematology. 2016 Review GET IT
Times cited: 26
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908). American journal of hematology. 2016 Academic Article GET IT
Times cited: 9
Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia. Cancer cell. 2016 Academic Article GET IT
Times cited: 66
Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups. Blood. 2016 Academic Article GET IT
Times cited: 72
Emerging therapeutic drugs for AML. Blood. 2015 Review GET IT
Times cited: 118
Molecular therapy for acute myeloid leukaemia. Nature reviews. Clinical oncology. 2015 Review GET IT
Times cited: 68
Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria. Clinical lymphoma, myeloma & leukemia. 2015 Academic Article GET IT
Times cited: 6
Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study. British journal of haematology. 2015 Academic Article GET IT
Times cited: 40
Hairy cell leukemia: Past, present and future. Best practice & research. Clinical haematology. 2015 Review GET IT
Times cited: 11
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias. Blood. 2015 Academic Article GET IT
Times cited: 19
High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia. Blood. 2015 Academic Article GET IT
Times cited: 16
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia. The New England journal of medicine. 2015 Academic Article GET IT
Times cited: 160
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 24
Cost-Effectiveness Analysis of Treating Acute Promyelocytic Leukemia Patients With Arsenic Trioxide and Retinoic Acid in the United States. Clinical lymphoma, myeloma & leukemia. 2015 Academic Article GET IT
Times cited: 13
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clinic proceedings. 2015 Article GET IT
Times cited: 105
Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center. British journal of haematology. 2015 Academic Article GET IT
Times cited: 11
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 9
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. Bone marrow transplantation. 2015 Academic Article GET IT
Times cited: 13
Acute promyelocytic leukemia: where did we start, where are we now, and the future. Blood cancer journal. 2015 Review GET IT
Times cited: 134
Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia. PloS one. 2015 Academic Article GET IT
Times cited: 4
Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia. Cancer cell. 2015 Academic Article GET IT
Times cited: 126
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997. Leukemia & lymphoma. 2015 Academic Article GET IT
Times cited: 6
Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy. British journal of haematology. 2015 Academic Article GET IT
Times cited: 17
Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia. Leukemia. 2015 Letter GET IT
Times cited: 41
Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study. Clinical lymphoma, myeloma & leukemia. 2015 Academic Article GET IT
Times cited: 29
Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 40
Mixed lineage rearranged leukaemia: pathogenesis and targeting DOT1L. Current opinion in hematology. 2015 Review GET IT
Times cited: 45
The best of times in hematologic malignancies. Current opinion in hematology. 2015 Editorial Article GET IT
Times cited: 1
High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?. Hematological oncology. 2015 Academic Article GET IT
Times cited: 10
Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program. The Journal of clinical investigation. 2015 Academic Article GET IT
Times cited: 45
Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition. Leukemia. 2015 Academic Article GET IT
Times cited: 28
Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 28
DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Cell reports. 2014 Academic Article GET IT
Times cited: 152
A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. Blood. 2014 Academic Article GET IT
Times cited: 61
A multicenter phase I/II study of obatoclax mesylate administered as a 3- or 24-hour infusion in older patients with previously untreated acute myeloid leukemia. PloS one. 2014 Academic Article GET IT
Times cited: 45
Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998). Leukemia. 2014 Academic Article GET IT
Times cited: 47
Acute promyelocytic leukemia in children and adolescents. Acta haematologica. 2014 Academic Article GET IT
Times cited: 10
The challenges and perspectives in treating adolescent and young adult patients with hematological malignancies. Acta haematologica. 2014 Editorial Article GET IT
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. Nature. 2014 Academic Article GET IT
Times cited: 221
Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemia. Cancer research. 2014 Academic Article GET IT
Times cited: 15
Acute promyelocytic leukemia: what is the new standard of care?. Blood reviews. 2014 Review GET IT
Times cited: 47
Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IPSS. British journal of haematology. 2014 Academic Article GET IT
Times cited: 24
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study. Annals of hematology. 2014 Academic Article GET IT
Times cited: 31
Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 10
Younger adults with acute myeloid leukemia in remission for ≥ 3 years have a high likelihood of cure: The ECOG experience in over 1200 patients. Leukemia research. 2014 Academic Article GET IT
Times cited: 7
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia. Science translational medicine. 2014 Academic Article GET IT
Times cited: 79
Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 2014 Academic Article GET IT
Times cited: 1
Acute promyelocytic leukemia. Best practice & research. Clinical haematology. 2014 Editorial Article GET IT
Times cited: 2
Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukaemia study. British journal of haematology. 2014 Academic Article GET IT
Times cited: 9
Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes. British journal of haematology. 2014 Academic Article GET IT
Times cited: 28
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML. Blood. 2014 Academic Article GET IT
Times cited: 211
Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 31
Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 158
Left behind: should minimal residual disease be treated in hairy cell leukemia?. Leukemia & lymphoma. 2014 Comment GET IT
Times cited: 4
Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 9
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy. British journal of haematology. 2014 Academic Article GET IT
Times cited: 27
Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 66
Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 37
Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants. Cancer genetics. 2014 Academic Article GET IT
Times cited: 5
High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome. Leukemia. 2013 Academic Article GET IT
Times cited: 18
Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432. Leukemia research. 2013 Academic Article GET IT
Times cited: 12
Postconsolidation maintenance and monitoring in patients with acute promyelocytic leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2013 Academic Article GET IT
Times cited: 2
Searching the central nervous system for relapsed acute promyelocytic leukemia. Leukemia & lymphoma. 2013 Comment GET IT
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia. Cancer cell. 2013 Academic Article GET IT
Times cited: 128
UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Blood. 2013 Academic Article GET IT
Times cited: 191
Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia. British journal of haematology. 2013 Academic Article GET IT
Times cited: 44
Acute myeloid leukemia, version 2.2013. Journal of the National Comprehensive Cancer Network : JNCCN. 2013 Review GET IT
Times cited: 103
Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes. Blood. 2013 Academic Article GET IT
Times cited: 29
Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood. 2013 Academic Article GET IT
Times cited: 73
Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 170
Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death. Leukemia research. 2013 Academic Article GET IT
Times cited: 58
Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia. Blood. 2013 Academic Article GET IT
Times cited: 82
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. Blood. 2013 Academic Article GET IT
Times cited: 118
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia. Blood. 2013 Academic Article GET IT
Times cited: 331
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129. Leukemia research. 2013 Academic Article GET IT
Times cited: 26
Incidence of sinusoidal obstruction syndrome following Mylotarg (gemtuzumab ozogamicin): a prospective observational study of 482 patients in routine clinical practice. International journal of hematology. 2013 Academic Article GET IT
Times cited: 24
Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational status. PloS one. 2013 Academic Article GET IT
Times cited: 5
Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. Nature medicine. 2013 Academic Article GET IT
Times cited: 218
Persistent problems with persistent disease: minimal residual disease in acute myelogenous leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Comment GET IT
The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial. Haematologica. 2013 Academic Article GET IT
Times cited: 30
Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL. Blood. 2013 Academic Article GET IT
Times cited: 57
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 50
A 75-year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma). Seminars in oncology. 2012 Academic Article GET IT
Times cited: 4
Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy--Leukemia (FACT-Leu) questionnaire. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2012 Academic Article GET IT
Times cited: 58
Translocation t(11;17) in de novo myelodysplastic syndrome not associated with acute myeloid or acute promyelocytic leukemia. Acta haematologica. 2012 Academic Article GET IT
Times cited: 2
A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern Network on Adverse Reactions (SONAR). Seminars in thrombosis and hemostasis. 2012 Review GET IT
Times cited: 27
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia. Cancer discovery. 2012 Academic Article GET IT
Times cited: 59
Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosis. Leukemia research. 2012 Academic Article GET IT
Times cited: 22
Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research. Haematologica. 2012 Academic Article GET IT
Times cited: 40
The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011). Leukemia & lymphoma. 2012 Academic Article GET IT
Times cited: 28
Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium. Leukemia research. 2012 Academic Article GET IT
Times cited: 28
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia. Blood. 2012 Academic Article GET IT
Times cited: 126
CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900. Blood. 2012 Academic Article GET IT
Times cited: 66
NCCN Clinical Practice Guidelines Acute myeloid leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2012 Review GET IT
Times cited: 193
IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 75
Remission induction in acute myeloid leukemia. International journal of hematology. 2012 Academic Article GET IT
Times cited: 13
Provocative pearls in diagnosing and treating acute promyelocytic leukemia. Oncology (Williston Park, N.Y.). 2012 Review GET IT
Times cited: 4
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia. Blood. 2012 Academic Article GET IT
Times cited: 38
Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia. PLoS genetics. 2012 Academic Article GET IT
Times cited: 198
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood. 2012 Academic Article GET IT
Times cited: 96
How I treat hematologic emergencies in adults with acute leukemia. Blood. 2012 Review GET IT
Times cited: 47
Novel and emerging drugs for acute myeloid leukemia. Current cancer drug targets. 2012 Review GET IT
Times cited: 12
Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17). Medical oncology (Northwood, London, England). 2012 Academic Article GET IT
Times cited: 13
Does arsenic trioxide impact fertility?. Leukemia & lymphoma. 2012 Comment GET IT
Times cited: 2
Novel therapeutic strategies for AML in 2012. Hematology (Amsterdam, Netherlands). 2012 Academic Article GET IT
Times cited: 4
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. The New England journal of medicine. 2012 Academic Article GET IT
Times cited: 1193
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. British journal of haematology. 2012 Academic Article GET IT
Times cited: 96
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era. Blood. 2012 Academic Article GET IT
Times cited: 39
Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 220
Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readouts. Cytometry. Part B, Clinical cytometry. 2012 Academic Article GET IT
Times cited: 24
"Boldness be my friend" (Shakespeare; Cymbeline). Blood. 2011 Comment GET IT
Times cited: 2
Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia. Leukemia research. 2011 Academic Article GET IT
Times cited: 18
Cutaneous involvement with B-lineage acute lymphoblastic leukemia. Leukemia & lymphoma. 2011 Letter GET IT
Times cited: 9
Acute leukemias. Hematology/oncology clinics of North America. 2011 Editorial Article GET IT
Curing all patients with acute promyelocytic leukemia: are we there yet?. Hematology/oncology clinics of North America. 2011 Review GET IT
Times cited: 14
A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma. American journal of hematology. 2011 Comment GET IT
Times cited: 15
Emerging new approaches for the treatment of acute promyelocytic leukemia. Therapeutic advances in hematology. 2011 Review GET IT
Times cited: 10
Managing acute promyelocytic leukemia without conventional chemotherapy: is it possible?. Expert review of hematology. 2011 Review GET IT
Times cited: 8
Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997. Blood. 2011 Academic Article GET IT
Times cited: 38
How I treat extramedullary acute myeloid leukemia. Blood. 2011 Review GET IT
Times cited: 230
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Academic Article GET IT
Times cited: 80
Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy. Oncology (Williston Park, N.Y.). 2011 Review GET IT
Times cited: 27
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 83
Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. 2011 Academic Article GET IT
Times cited: 231
Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study. Clinical lymphoma, myeloma & leukemia. 2011 Academic Article GET IT
Times cited: 40
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia. Investigational new drugs. 2011 Academic Article GET IT
Times cited: 29
Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping. Leukemia & lymphoma. 2011 Academic Article GET IT
Times cited: 14
Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin. Blood. 2011 Academic Article GET IT
Times cited: 51
Acute myeloid leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2011 Review GET IT
Times cited: 44
Blood consult: acute myeloid leukemia and the t(8;21)(q22;22). Blood. 2011 Academic Article GET IT
Times cited: 1
Clinical roundtable monograph. Early death in patients with acute promyelocytic leukemia. Clinical advances in hematology & oncology : H&O. 2011 Academic Article GET IT
Times cited: 5
Early death in patients with acute promyelocytic leukemia. Proceedings from a live roundtable at the 2010 American Society of Hematology Annual Meeting, December 4–7, 2010, Orlando, Florida. Clinical advances in hematology & oncology : H&O. 2011 Conference Paper GET IT
Times cited: 15
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. Blood. 2011 Academic Article GET IT
Times cited: 279
Don't just stand there, do something: strategies for the prevention of early death in acute promyelocytic leukemia: a commentary. Blood cells, molecules & diseases. 2011 Comment GET IT
Times cited: 9
The 12th international conference on differentiation therapy: targeting the aberrant growth, differentiation and cell death programs of cancer cells. Cell death and differentiation. 2011 Conference Paper GET IT
Times cited: 5
The hematopoietic growth factors in acute leukemia: U.S. perspective. Cancer treatment and research. 2011 Review GET IT
Times cited: 2
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer cell. 2010 Academic Article GET IT
Times cited: 1650
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns. Blood. 2010 Review GET IT
Times cited: 129
Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group. Cancer. 2010 Academic Article GET IT
Times cited: 81
PHF6 mutations in adult acute myeloid leukemia. Leukemia. 2010 Academic Article GET IT
Times cited: 94
Charcot-Leyden crystals associated with acute myeloid leukemia: case report and literature review. Leukemia research. 2010 Letter GET IT
Times cited: 3
Hypomethylating agents in acute lymphoblastic leukemia: untapped potential?. Leukemia & lymphoma. 2010 Comment GET IT
Times cited: 1
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?. American journal of hematology. 2010 Letter GET IT
Times cited: 2
Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy. Clinical lymphoma, myeloma & leukemia. 2010 Academic Article GET IT
Times cited: 9
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group. Blood. 2010 Academic Article GET IT
Times cited: 23
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. Blood. 2010 Academic Article GET IT
Times cited: 143
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. Blood. 2010 Academic Article GET IT
Times cited: 256
Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?. Leukemia research. 2010 Editorial Article GET IT
Times cited: 14
Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses. Molecular pharmacology. 2010 Academic Article GET IT
Times cited: 27
Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide. The Journal of biological chemistry. 2010 Academic Article GET IT
Times cited: 103
Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903. Blood. 2010 Academic Article GET IT
Times cited: 93
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 260
How I treat acute myeloid leukemia. Blood. 2010 Academic Article GET IT
Times cited: 123
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood. 2010 Academic Article GET IT
Times cited: 133
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm. Blood. 2010 Review GET IT
Times cited: 57
Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast cancer research : BCR. 2010 Academic Article GET IT
Times cited: 45
All-trans retinoic acid and arsenic rescue patients with acute promyelocytic leukemia from a potential 'perfect storm'. Leukemia & lymphoma. 2010 Comment GET IT
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Blood. 2010 Academic Article GET IT
Times cited: 129
Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 345
Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 129
Sorafenib - a small molecule with big promise?. Leukemia & lymphoma. 2010 Comment GET IT
Times cited: 3
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. 2009 Academic Article GET IT
Times cited: 145
How I treat acute promyelocytic leukemia. Blood. 2009 Review GET IT
Times cited: 198
T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Blood. 2009 Academic Article GET IT
Times cited: 216
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129. Pediatric blood & cancer. 2009 Academic Article GET IT
Times cited: 26
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2009 Review GET IT
Times cited: 2261
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group. British journal of haematology. 2009 Academic Article GET IT
Times cited: 48
Historical aspects and milestones in the development of effective treatment for hairy cell leukemia. Leukemia & lymphoma. 2009 Review GET IT
Times cited: 2
NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2009 Review GET IT
Times cited: 58
Anthracycline dose intensification in acute myeloid leukemia. The New England journal of medicine. 2009 Academic Article GET IT
Times cited: 589
Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma. 2009 Academic Article GET IT
Times cited: 19
Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse. Blood. 2009 Academic Article GET IT
Times cited: 41
Mutational analysis of candidate tumor-associated genes in acute megakaryoblastic leukemia. Leukemia. 2009 Academic Article GET IT
Times cited: 3
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood. 2009 Academic Article GET IT
Times cited: 256
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 97
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 65
Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 73
Bing-Neel syndrome: an illustrative case and a comprehensive review of the published literature. Journal of neuro-oncology. 2009 Review GET IT
Times cited: 39
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996). Blood. 2009 Academic Article GET IT
Times cited: 140
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 19
Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer. Cancer research. 2009 Academic Article GET IT
Times cited: 33
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009 Academic Article GET IT
Times cited: 488
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up. Blood. 2009 Academic Article GET IT
Times cited: 140
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 73
Myeloid disease. Current opinion in hematology. 2009 Editorial Article GET IT
The coagulopathy of acute promyelocytic leukaemia revisited. Best practice & research. Clinical haematology. 2009 Review GET IT
Times cited: 99
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. Blood. 2009 Academic Article GET IT
Times cited: 199
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney international. Supplement. 2009 Conference Paper GET IT
Times cited: 66
'Ghostbusting' at blood. Blood. 2009 Editorial Article GET IT
Times cited: 8
Myeloid growth factors. Journal of the National Comprehensive Cancer Network : JNCCN. 2009 Academic Article GET IT
Times cited: 39
Role of hematopoietic stem cell transplantation in acute myelogenous leukemia and myelodysplastic syndrome. Cancer treatment and research. 2009 Review GET IT
Times cited: 1
Treatment of elderly adults with acute promyelocytic leukemia: put the pedal to metal. Leukemia & lymphoma. 2009 Comment GET IT
Times cited: 5
What is the role of arsenic in newly diagnosed APL?. Best practice & research. Clinical haematology. 2008 Review GET IT
Times cited: 28
Acute myeloid leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2008 Academic Article GET IT
Times cited: 9
Existing and emerging therapeutic options for the treatment of acute myeloid leukemia. Clinical advances in hematology & oncology : H&O. 2008 Academic Article GET IT
Times cited: 2
Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?. Bone marrow transplantation. 2008 Academic Article GET IT
Times cited: 7
Myelodysplastic syndromes. Journal of the National Comprehensive Cancer Network : JNCCN. 2008 Review GET IT
Times cited: 18
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2008 Review GET IT
Times cited: 647
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood. 2008 Academic Article GET IT
Times cited: 57
Introduction: Proceedings from the 9th Novo Nordisk Symposium on Haemostasis Management. Seminars in hematology. 2008 Editorial Article GET IT
Monitoring inhibitor patients with the right assays. Seminars in hematology. 2008 Academic Article GET IT
Times cited: 13
Myeloid disease. Current opinion in hematology. 2008 Editorial Article GET IT
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. 2008 Review GET IT
Times cited: 597
Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2. The Journal of biological chemistry. 2008 Academic Article GET IT
Times cited: 31
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Review GET IT
Times cited: 59
Acute myeloid leukemia; decided victories, disappointments, and detente: an historical perspective. Hematology. American Society of Hematology. Education Program. 2008 Editorial Article GET IT
Times cited: 2
Curative strategies in acute promyelocytic leukemia. Hematology. American Society of Hematology. Education Program. 2008 Academic Article GET IT
Times cited: 51
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2007 Academic Article GET IT
Times cited: 39
A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma. British journal of haematology. 2007 Academic Article GET IT
Times cited: 40
Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure. Acta haematologica. 2007 Academic Article GET IT
Times cited: 2
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood. 2007 Academic Article GET IT
Times cited: 507
Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses. The Journal of biological chemistry. 2007 Academic Article GET IT
Times cited: 38
Molecular characterization of acute myeloid leukemia and its impact on treatment. Current opinion in oncology. 2007 Review GET IT
Times cited: 24
Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival. Blood. 2007 Academic Article GET IT
Times cited: 53
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone marrow transplantation. 2007 Academic Article GET IT
Times cited: 172
Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone marrow transplantation. 2007 Review GET IT
Times cited: 131
The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia. Seminars in thrombosis and hemostasis. 2007 Review GET IT
Times cited: 47
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Archives of internal medicine. 2007 Academic Article GET IT
Times cited: 39
Chronic myelogenous leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2007 Review GET IT
Times cited: 9
Suppressive effects of statins on acute promyelocytic leukemia cells. Cancer research. 2007 Academic Article GET IT
Times cited: 68
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. British journal of haematology. 2007 Academic Article GET IT
Times cited: 67
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients. Cancer. 2007 Academic Article GET IT
Times cited: 179
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission. Blood. 2007 Academic Article GET IT
Times cited: 62
Treatment of relapsed or refractory acute promyelocytic leukemia. Best practice & research. Clinical haematology. 2007 Review GET IT
Times cited: 94
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone marrow transplantation. 2007 Academic Article GET IT
Times cited: 170
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 29
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 276
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Academic Article GET IT
Times cited: 345
Growth factors in leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2007 Review GET IT
Times cited: 17
Myeloid growth factors. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2007 Conference Paper GET IT
Times cited: 54
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood. 2006 Academic Article GET IT
Times cited: 491
End points to establish the efficacy of new agents in the treatment of acute leukemia. Blood. 2006 Review GET IT
Times cited: 63
2-CdA in the treatment of hairy cell leukemia: a review of long-term follow-up. Leukemia & lymphoma. 2006 Review GET IT
Times cited: 12
Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cells. Molecular cancer therapeutics. 2006 Academic Article GET IT
Times cited: 25
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. British journal of haematology. 2006 Review GET IT
Times cited: 122
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood. 2006 Academic Article GET IT
Times cited: 509
Hairy cell leukemia: towards a curative strategy. Hematology/oncology clinics of North America. 2006 Review GET IT
Times cited: 6
Monoclonal antibodies for the treatment of acute myeloid leukemia. Current pharmaceutical biotechnology. 2006 Review GET IT
Times cited: 30
Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900). Leukemia research. 2006 Academic Article GET IT
Times cited: 13
Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leukemia research. 2006 Academic Article GET IT
Times cited: 128
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations. British journal of haematology. 2006 Academic Article GET IT
Times cited: 174
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia. Haematologica. 2006 Academic Article GET IT
Times cited: 15
Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses. Cancer research. 2006 Academic Article GET IT
Times cited: 72
Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide. The Journal of biological chemistry. 2006 Academic Article GET IT
Times cited: 47
Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?. Bone marrow transplantation. 2006 Academic Article GET IT
Times cited: 38
Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia. Bone marrow transplantation. 2006 Review GET IT
Times cited: 65
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies. Leukemia. 2006 Letter GET IT
Times cited: 79
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. Blood. 2006 Academic Article GET IT
Times cited: 137
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation. 2006 Academic Article GET IT
Times cited: 13
Immunophenotypic variations in hairy cell leukemia. American journal of clinical pathology. 2006 Academic Article GET IT
Times cited: 74
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2006 Academic Article GET IT
Times cited: 24
Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997. Leukemia research. 2006 Academic Article GET IT
Times cited: 5
Acute myeloid leukemia clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2006 Review GET IT
Times cited: 18
Immune therapy in haematological malignancies. Best practice & research. Clinical haematology. 2006 Editorial Article GET IT
Myelodysplastic syndromes clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2006 Review GET IT
Times cited: 45
New agents for the treatment of acute myeloid leukemia. Best practice & research. Clinical haematology. 2006 Review GET IT
Times cited: 43
Strategies for the treatment of acute promyelocytic leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2006 Review GET IT
Times cited: 11
Chronic myelogenous leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. 2005 Review GET IT
Times cited: 4
Practice points, consensus, and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia. The oncologist. 2005 Review GET IT
Times cited: 21
T-cell non-Hodgkin lymphoma. Blood. 2005 Review GET IT
Times cited: 156
Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes. Cancer research. 2005 Academic Article GET IT
Times cited: 51
Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF. Bone marrow transplantation. 2005 Academic Article GET IT
Times cited: 10
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood. 2005 Academic Article GET IT
Times cited: 443
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood. 2005 Review GET IT
Times cited: 70
The Research on Adverse Drug Events and Reports (RADAR) project. JAMA. 2005 Academic Article GET IT
Times cited: 104
Drug therapy for acute myeloid leukemia. Blood. 2005 Review GET IT
Times cited: 500
Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells. Experimental hematology. 2005 Academic Article GET IT
Times cited: 30
Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells. Blood. 2005 Academic Article GET IT
Times cited: 55
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood. 2005 Academic Article GET IT
Times cited: 119
Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom. Leukemia research. 2005 Conference Paper GET IT
Times cited: 49
Prognosis of acute monocytic leukemia (French-American-British classification M5). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Letter GET IT
Times cited: 6
Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapy. Cancer research. 2005 Conference Paper GET IT
Times cited: 16
Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?. Bone marrow transplantation. 2005 Academic Article GET IT
Times cited: 32
Hairy cell leukemia: survival and relapse. Long-term follow-up of purine analog-based therapy and approach for relapsed disease. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2005 Conference Paper GET IT
Times cited: 13
Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia. Cytometry. Part B, Clinical cytometry. 2005 Academic Article GET IT
Times cited: 12
Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995). Leukemia & lymphoma. 2005 Academic Article GET IT
Times cited: 21
New strategies for the treatment of acute myeloid leukemia including antibodies and other novel agents. Hematology. American Society of Hematology. Education Program. 2005 Academic Article GET IT
Times cited: 57
Phase II pilot trial of gemtuzumab ozogamicin (GO) as first line therapy in acute myeloid leukemia patients age 65 or older. Leukemia research. 2005 Academic Article GET IT
Times cited: 61
Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood. 2004 Review GET IT
Times cited: 109
Treatment of acute promyelocytic leukemia in the very elderly: case report and review of the literature. Leukemia research. 2004 Academic Article GET IT
Times cited: 10
A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL). Leukemia & lymphoma. 2004 Academic Article GET IT
Times cited: 59
Activation of the p70 S6 kinase by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood. 2004 Academic Article GET IT
Times cited: 35
Extramedullary acute myeloid leukemia infiltrates. Leukemia research. 2004 Editorial Article GET IT
Times cited: 3
Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998). Leukemia. 2004 Academic Article GET IT
Times cited: 19
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone marrow transplantation. 2004 Academic Article GET IT
Times cited: 164
Pure red-cell aplasia and epoetin therapy. The New England journal of medicine. 2004 Academic Article GET IT
Times cited: 361
Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old. Leukemia research. 2004 Academic Article GET IT
Times cited: 38
The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future. Leukemia research. 2004 Review GET IT
Times cited: 146
Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia. Journal of thrombosis and haemostasis : JTH. 2004 Academic Article GET IT
Times cited: 106
Gemtuzumab ozogamicin (MylotargTM) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive disease. Annals of oncology : official journal of the European Society for Medical Oncology. 2004 Review GET IT
Times cited: 22
Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): a trial of the Eastern Cooperative Oncology Group. Leukemia research. 2004 Academic Article GET IT
Times cited: 11
Intravascular clotting activation and bleeding in patients with hematologic malignancies. Reviews in clinical and experimental hematology. 2004 Review GET IT
Times cited: 14
A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Cytometry. Part B, Clinical cytometry. 2004 Academic Article GET IT
Times cited: 73
Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era. Leukemia research. 2004 Review GET IT
Times cited: 54
Acute promyelocytic leukemia as a paradigm for targeted therapy. Seminars in hematology. 2004 Academic Article GET IT
Times cited: 37
How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients?. Bone marrow transplantation. 2004 Academic Article GET IT
Times cited: 5
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia. Cancer. 2004 Academic Article GET IT
Times cited: 34
Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells. The Journal of biological chemistry. 2004 Academic Article GET IT
Times cited: 58
Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias. Blood. 2004 Academic Article GET IT
Times cited: 79
Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 191
Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 57
Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation?. Bone marrow transplantation. 2004 Academic Article GET IT
Times cited: 10
Relevance of pathologic classifications and diagnosis of acute myeloid leukemia to clinical trials and clinical practice. Cancer treatment and research. 2004 Review GET IT
Times cited: 18
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 1886
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study. Leukemia research. 2003 Academic Article GET IT
Times cited: 70
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 Academic Article GET IT
Times cited: 61
Current management and new approaches in the treatment of APL. Clinical advances in hematology & oncology : H&O. 2003 Academic Article GET IT
Times cited: 1
A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group. Blood. 2003 Academic Article GET IT
Times cited: 224
All-trans retinoic acid in acute promyelocytic leukaemia. Best practice & research. Clinical haematology. 2003 Academic Article GET IT
Times cited: 39
Long-term follow-up and potential for cure in acute promyelocytic leukaemia. Best practice & research. Clinical haematology. 2003 Academic Article GET IT
Times cited: 10
Retinoic acid syndrome: manifestations, pathogenesis, and treatment. Best practice & research. Clinical haematology. 2003 Review GET IT
Times cited: 82
Acute promyelocytic leukaemia:a review. Expert opinion on pharmacotherapy. 2003 Review GET IT
Times cited: 50
Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials. Leukemia. 2003 Academic Article GET IT
Times cited: 13
New developments in antibody therapy for acute myeloid leukemia. Seminars in oncology. 2003 Academic Article GET IT
Times cited: 17
Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer. The New England journal of medicine. 2003 Academic Article GET IT
Times cited: 158
Activation of protein kinase C delta by all-trans-retinoic acid. The Journal of biological chemistry. 2003 Academic Article GET IT
Times cited: 94
Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status. American journal of clinical pathology. 2003 Academic Article GET IT
Times cited: 31
Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?. Bone marrow transplantation. 2003 Academic Article GET IT
Times cited: 14
Biphenotypic acute leukemia with coexpression of CD79a and markers of myeloid lineage. Archives of pathology & laboratory medicine. 2003 Academic Article GET IT
Times cited: 13
Splenectomy and treatments of historical interest. Best practice & research. Clinical haematology. 2003 Review GET IT
Times cited: 20
Acute myeloid leukemia and acute promyelocytic leukemia. Hematology. American Society of Hematology. Education Program. 2003 Review GET IT
Times cited: 87
Bleeding in acute leukemia. Pathophysiology of haemostasis and thrombosis. 2003 Conference Paper GET IT
Times cited: 1
Superior sagittal sinus thrombosis in a patient with postdural puncture headache. Regional anesthesia and pain medicine. 2003 Academic Article GET IT
Times cited: 25
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood. 2002 Academic Article GET IT
Times cited: 127
Current treatment strategies for patients with hairy cell leukemia. Reviews in clinical and experimental hematology. 2002 Review GET IT
Times cited: 16
Reassessing the definition of myeloid engraftment after autotransplantation: it is not necessary to see 0.5 x 10(9)/l neutrophils on 3 consecutive days to define myeloid recovery. Bone marrow transplantation. 2002 Academic Article GET IT
Times cited: 13
Hairy cell leukemia presenting as localized skeletal involvement. Leukemia & lymphoma. 2002 Academic Article GET IT
Times cited: 14
Secondary acute myelogenous leukemia with MLL gene rearrangement following radioimmunotherapy (RAIT) for non-Hodgkin's lymphoma. Leukemia & lymphoma. 2002 Academic Article GET IT
Times cited: 10
Advancing the treatment of hematologic malignancies through the development of targeted interventions. Seminars in hematology. 2002 Academic Article GET IT
Times cited: 8
Monoclonal antibody therapies in leukemias. Seminars in hematology. 2002 Academic Article GET IT
Times cited: 28
Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea. Bone marrow transplantation. 2002 Academic Article GET IT
Times cited: 33
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). Leukemia. 2002 Academic Article GET IT
Times cited: 194
Management of acute promyelocytic leukemia. Current oncology reports. 2002 Review GET IT
Times cited: 22
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood. 2002 Academic Article GET IT
Times cited: 356
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia. Cancer. 2002 Academic Article GET IT
Times cited: 24
Focus on acute leukemias. Cancer cell. 2002 Review GET IT
Times cited: 145
Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders. American journal of clinical pathology. 2002 Academic Article GET IT
Times cited: 57
Cobe Spectra is superior to Fenwal CS 3000 Plus for collection of hematopoietic stem cells. Bone marrow transplantation. 2002 Academic Article GET IT
Times cited: 20
Established practice in the treatment of patients with acute promyleocytic leukemia and the introduction of arsenic trioxide as a novel therapy. Seminars in hematology. 2002 Review GET IT
Times cited: 44
Introduction. Seminars in hematology. 2002 Review GET IT
Understanding the action of interferon in hairy cell leukemia: the past as prologue. Leukemia research. 2002 Comment GET IT
Early phase I/II trials with gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemia. Clinical lymphoma. 2002 Academic Article GET IT
Times cited: 26
Acute promyelocytic leukemia: evolving therapeutic strategies. Blood. 2002 Review GET IT
Times cited: 346
Retinoic acid syndrome: a problem of the past?. Leukemia. 2002 Academic Article GET IT
Times cited: 19
Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide. The oncologist. 2002 Conference Paper GET IT
Times cited: 32
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Academic Article GET IT
Times cited: 664
Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies. Blood reviews. 2001 Academic Article GET IT
Times cited: 22
CD34(+) cell collection efficiency does not correlate with the pre-leukapheresis hematocrit. Bone marrow transplantation. 2001 Academic Article GET IT
Times cited: 18
The role of bone marrow transplantation in acute promyelocytic leukemia. Bone marrow transplantation. 2001 Review GET IT
Times cited: 42
Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood. 2001 Academic Article GET IT
Times cited: 125
Criteria for diagnosis of acute megakaryocytic leukemia. Blood. 2001 Letter GET IT
Changes in finances, insurance, employment, and lifestyle among persons diagnosed with hairy cell leukemia. The oncologist. 2001 Academic Article GET IT
Times cited: 14
Therapy of acute myeloid leukemia. Cancer control : journal of the Moffitt Cancer Center. 2001 Review GET IT
Times cited: 23
NCCN Practice Guidelines for Acute Myelogenous Leukemia. Oncology (Williston Park, N.Y.). 2000 Academic Article GET IT
Times cited: 25
NCCN Practice Guidelines for Chronic Myelogenous Leukemia. Oncology (Williston Park, N.Y.). 2000 Academic Article GET IT
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood. 2000 Academic Article GET IT
Times cited: 107
Phase II trial of 2-chlorodeoxyadenosine in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group (ECOG), E5995. Leukemia research. 2000 Academic Article GET IT
Times cited: 23
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood. 2000 Academic Article GET IT
Times cited: 91
Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology Group. Leukemia. 2000 Academic Article GET IT
Times cited: 21
Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making. Leukemia & lymphoma. 2000 Academic Article GET IT
Times cited: 28
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129. Blood. 2000 Academic Article GET IT
Times cited: 51
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood. 2000 Academic Article GET IT
Times cited: 215
The association between physician reimbursement in the US and use of hematopoietic colony stimulating factors as adjunct therapy for older patients with acute myeloid leukemia: results from the 1997 American Society of Clinical Oncology survey. Health Services Research Committee of the American Society of Clinical Oncology. Annals of oncology : official journal of the European Society for Medical Oncology. 1999 Academic Article GET IT
Times cited: 19
Technetium-99m sulfur colloid scanning and correlative magnetic resonance imaging in patients with hairy cell leukemia and hypocellular bone marrow biopsies after 2-chlorodeoxyadenosine. Leukemia & lymphoma. 1999 Academic Article GET IT
Times cited: 5
Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse. Clinical cancer research : an official journal of the American Association for Cancer Research. 1999 Academic Article GET IT
Times cited: 82
Immunohistochemical detection of breast cancer cells in paired peripheral blood progenitor cell specimens collected after cytokine or cytokine and myelosuppressive chemotherapy. Bone marrow transplantation. 1999 Academic Article GET IT
Times cited: 7
Treatment of hairy-cell leukemia: current views. Seminars in hematology. 1999 Academic Article GET IT
Times cited: 40
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490). Annals of oncology : official journal of the European Society for Medical Oncology. 1999 Academic Article GET IT
Times cited: 44
Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar). Blood. 1999 Academic Article GET IT
Times cited: 152
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study. Cancer. 1999 Academic Article GET IT
Times cited: 38
The thrombophilic state in acute promyelocytic leukemia. Seminars in thrombosis and hemostasis. 1999 Review GET IT
Times cited: 23
Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC). Advances in experimental medicine and biology. 1999 Academic Article GET IT
Times cited: 37
Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells. Cancer research. 1998 Academic Article GET IT
Times cited: 24
NCCN practice guidelines for the myelodysplastic syndromes. National Comprehensive Cancer Network. Oncology (Williston Park, N.Y.). 1998 Conference Paper GET IT
Times cited: 28
Roundtable discussion: Incorporating bone marrow transplantation into NCCN guidelines. Oncology (Williston Park, N.Y.). 1998 Academic Article GET IT
Times cited: 1
Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond. Leukemia. 1998 Conference Paper GET IT
Times cited: 51
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
Times cited: 139
Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood. 1998 Academic Article GET IT
Times cited: 110
Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma. Cancer. 1998 Academic Article GET IT
Times cited: 28
Massive splenomegaly in hairy cell leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
All-trans-retinoic acid in acute promyelocytic leukemia. The New England journal of medicine. 1998 Letter GET IT
Times cited: 17
Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology Group. British journal of haematology. 1998 Academic Article GET IT
Times cited: 44
High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancer. Cancer chemotherapy and pharmacology. 1998 Conference Paper GET IT
Times cited: 5
Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience. Cancer. 1997 Review GET IT
Times cited: 99
High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer. Bone marrow transplantation. 1997 Academic Article GET IT
Times cited: 5
All-trans-retinoic acid in acute promyelocytic leukemia. The New England journal of medicine. 1997 Academic Article GET IT
Times cited: 811
Intensifying induction therapy in acute myeloid leukemia: has a new standard of care emerged?. Blood. 1997 Editorial Article GET IT
Times cited: 50
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study. Blood. 1997 Academic Article GET IT
Times cited: 106
Hypocholesterolemia in hairy cell leukemia: a marker for proliferative activity. American journal of hematology. 1997 Academic Article GET IT
Times cited: 15
RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study. Blood. 1997 Academic Article GET IT
Times cited: 41
2-Chlorodeoxyadenosine in cutaneous T-cell lymphoproliferative disorders. Leukemia & lymphoma. 1997 Academic Article GET IT
Times cited: 27
2-Chlorodeoxyadenosine treatment in the Sezary syndrome. Blood. 1997 Letter GET IT
Times cited: 5
Economic analyses of phase III cooperative cancer group clinical trials: are they feasible?. Cancer investigation. 1997 Academic Article GET IT
Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA). Leukemia. 1997 Letter GET IT
Times cited: 22
All-trans retinoic acid, low-dose cytosine arabinoside and granulocyte colony-stimulating factor in acute myelogenous leukemia: update of an illinois cancer center phase d pilot study. Experimental Hematology. 1996 Article
High-dose chemotherapy for breast cancer. Annals of internal medicine. 1996 Review GET IT
Times cited: 29
Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience. Blood. 1996 Academic Article GET IT
Times cited: 95
Differentiating therapy in acute myeloid leukemia. Leukemia. 1996 Academic Article GET IT
Times cited: 47
Differentiating therapy in acute myeloid leukemia. Leukemia. 1996 Academic Article GET IT
Times cited: 1
Differentiating therapy with all-trans retinoic acid in acute myeloid leukemia. Leukemia. 1996 Conference Paper GET IT
Times cited: 28
Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia. American journal of clinical pathology. 1996 Academic Article GET IT
Times cited: 55
Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Blood. 1996 Academic Article GET IT
Times cited: 89
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma. Blood. 1996 Academic Article GET IT
Times cited: 79
Current results and prospective trials of cladribine in chronic lymphocytic leukemia. Seminars in hematology. 1996 Review GET IT
Times cited: 4
Deciphering the pathogenesis of coagulation dysfunction in leukemia. Leukemia research. 1996 Comment GET IT
Times cited: 7
Good things come in small packages. Cancer investigation. 1996 Editorial Article GET IT
Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1996 Academic Article GET IT
Rapidly progressive cutaneous vasculitis in a patient with chronic myelomonocytic leukemia. American journal of hematology. 1995 Academic Article GET IT
Times cited: 12
Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood. 1995 Review GET IT
Times cited: 154
Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood. 1995 Academic Article GET IT
Times cited: 88
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 91
Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1995 Academic Article GET IT
Times cited: 64
Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity. Free radical biology & medicine. 1995 Academic Article GET IT
Times cited: 60
Developments in the treatment of acute leukemia in adults. Current opinion in oncology. 1995 Review GET IT
Times cited: 6
All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies. Seminars in hematology. 1994 Conference Paper GET IT
Times cited: 21
Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid. Blood reviews. 1994 Academic Article GET IT
Times cited: 9
2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 79
A Phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer: an Illinois cancer center study. Cancer. 1994 Letter GET IT
Times cited: 3
Prospective evaluation of internal adenopathy in a cohort of 43 patients with hairy cell leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1994 Academic Article GET IT
Times cited: 24
Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index. Leukemia & lymphoma. 1994 Conference Paper GET IT
Times cited: 3
Combined therapy with rG-CSF and GM-CSF for the mobilization of hematopoietic progenitor cells. Progress in clinical and biological research. 1994 Academic Article GET IT
Times cited: 1
Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood. 1993 Academic Article GET IT
Times cited: 454
A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study. Cancer. 1993 Academic Article GET IT
Times cited: 39
Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood. 1993 Academic Article GET IT
Times cited: 65
New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia. Leukemia & lymphoma. 1993 Academic Article GET IT
Times cited: 52
Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Leukemia. 1993 Academic Article GET IT
Times cited: 23
Basophilic differentiation in acute promyelocytic leukemia. Leukemia. 1993 Academic Article GET IT
Times cited: 28
Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1993 Academic Article GET IT
Times cited: 195
A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood. 1992 Academic Article GET IT
Times cited: 122
Retinoids in cancer treatment. Journal of clinical pharmacology. 1992 Review GET IT
Times cited: 77
Treatment of acute promyelocytic leukemia. Blood. 1992 Letter GET IT
Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood. 1992 Review GET IT
Times cited: 274
Detection of differentiation in acute promyelocytic leukemia. Blood. 1991 Letter GET IT
Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1991 Academic Article GET IT
Times cited: 6
Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disorders. American journal of clinical pathology. 1991 Academic Article GET IT
Times cited: 16
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1989 Academic Article GET IT
Times cited: 25
Influence of infusion duration on the efficacy and toxicity of intravenous cyclosporine in bone marrow transplant patients. Transplantation proceedings. 1988 Academic Article GET IT
Times cited: 2
Comparison of two intravenous cyclosporine infusion schedules in marrow transplant recipients. Transplantation. 1988 Comment GET IT
Times cited: 5
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. Bone marrow transplantation. 1987 Academic Article GET IT
Times cited: 134
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1987 Academic Article GET IT
Bone marrow transplantation in a patient with myelodysplasia associated with diffuse eosinophilic fasciitis. American journal of hematology. 1987 Academic Article GET IT
Times cited: 13
Hereditary sensory neuropathy with macular dystrophy. Southern medical journal. 1985 Academic Article GET IT
Polymicrobial septicemia associated with rhabdomyolysis, myoglobinuria, and acute renal failure. Archives of internal medicine. 1982 Academic Article GET IT
Times cited: 17

more ...

less ...

Background

education and training

M.D., Chicago Medical School, Rosalind Franklin University of Medicine and Science 1980
B.S., University of Michigan 1976

Contact

full name

Martin Tallman

VIVO Weill Cornell Medical College

Martin Tallman Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name